(Adds details)
NEW DELHI, Jan 2 (Reuters) - India has approved the COVID-19
vaccine developed by AstraZeneca and Oxford University,
paving the way for a huge immunisation campaign in the world's
second most populous country.
Information and Broadcasting Minister Prakash Javadekar told
reporters on Saturday the vaccine had been approved on Friday,
confirming what sources close to the matter had told Reuters.
It is the first COVID-19 vaccine to be approved for
emergency use by India, which has the highest number of
infections after the United States.
Javadekar said at least three more vaccines were waiting in
line to be approved.
"India is perhaps the only country where at least four
vaccines are getting ready," he said.
"One was approved yesterday for emergency use, Serum's
COVISHIELD." he said, referring to the fact that the shot is
being made locally by the Serum Institute of India (SII).
India has reported more than 10 million COVID-19 cases,
though its rate of infection has come down significantly from a
mid-September peak.
The country hopes to inoculate 300 million of its 1.35
billion people in the first six to eight months of 2021.
(Reporting by Krishna N. Das; Editing by Kim Coghill and Mark
Potter)
Astrazeneca (AZN)
